1. Medtech Insight
  2. >>Digital Technologies
  3. >>AI

Exec Chat: Cumulus Neuroscience Help Trials Collect Previously Underutilized, Vital Data

 
• By Barnaby Pickering

Cumulus Neuroscience, previously known as BrainWaveBank, announced a £6m financing round to help develop its unique neurological data collection system.

Cumulus' EEG headset • Source: Cumulus Neuroscience

Electroencephalography (EEG), the technology for measuring electrical signals via sensors placed on the scalp, can provide a huge quantity of data on the function of a patient’s brain.

As clinical trials demand more data for analysis, the development of low-profile, effective, and affordable devices hastened. Cumulus Neuroscience, formerly...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from AI

From Risk Aversion to Real-World Impact: How Medtech Firms Can Harness AI

 
• By Elizabeth Orr

Medical device companies are increasingly using AI to improve regulatory affairs strategies but face barriers such as risk aversion, regulatory clarity and data governance issues. Experts suggest a design control approach and human oversight to ensure successful AI integration.

Medtech Sees Bigger Deals As Early Funding Tightens; LSI Is ‘Cautiously Optimistic’ For 2026

 
• By Marion Webb

Medtech funding in 2025 sees a trend of fewer, yet larger deals with total funding of $3.6bn in Q1, $2.6bn in Q2 and $2.9bn in Q3, said LSI’s Nick Talamantes. In 2026, he expects a continued investor focus on more mature firms in areas of oncology, cardiology and neurology.

Getting Comfortable With The Black Box: Explainable AI Techniques Build Trust

 
• By Bridget Silverman

A subfield of AI aims to explain why complex models make predictions, which will increase their interpretability and auditing ability, AI researcher Su-In Lee said during a National Academies of Sciences workshop.

FDA Staff Warn Device AI Hallucinations Could Harm Patient Care

 
• By Brian Bossetta

Hallucinations are a common problem in AI and pose significant challenges to medical devices powered by the technology. A paper authored by several FDA staffers argues that focusing on how hallucinations impact patients is the best approach.

More from Digital Technologies

FDA Staff Warn Device AI Hallucinations Could Harm Patient Care

 
• By Brian Bossetta

Hallucinations are a common problem in AI and pose significant challenges to medical devices powered by the technology. A paper authored by several FDA staffers argues that focusing on how hallucinations impact patients is the best approach.

Masimo Awarded $634M In Apple Patient Monitoring Patent Fight

 
• By Elizabeth Orr

A California jury found in favor of device firm Masimo in a long-running legal battle against the tech giant. Apple has already announced plans to appeal.

Digital Health Roundup: BCIs Surge Ahead, Oura Eyes BP Clearance, AI Faces New Scrutiny

 
• By Marion Webb, Brian Bossetta, Elizabeth Orr, and Shubham Singh

Brain-computer interfaces advance toward trials and commercialization, Oura pushes for FDA-cleared blood pressure monitoring, and regulators weigh AI’s expanding role in mental health and diagnostics amid rising safety concerns.